This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Baxter Healthcare Sa, Baxter International Inc., Nanotherapeutics, Inc.. Active years: 2014-2016.
Company Filing History:
1 out of 1,198 
1 out of 2,530 
1 out of 16 
Years Active: 2014-2016
Title: Simone Feigl: Innovator in Cell Line Production
Introduction
Simone Feigl is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the production of continuous cell lines. With a total of 2 patents, her work has the potential to advance research and applications in various medical and scientific domains.
Latest Patents
Feigl's latest patents focus on a method for producing continuous cell lines. The first patent describes a process that involves providing living cells from an animal or human, irradiating these cells with UV light, proliferating them, and selecting multiplying cells to establish a continuous cell line. This innovative approach enhances the efficiency and effectiveness of cell line production, which is crucial for various research applications.
Career Highlights
Throughout her career, Simone Feigl has worked with notable companies in the biotechnology sector. She has been associated with Nanotherapeutics, Inc. and Baxter International Inc., where she has contributed her expertise in cell line development and biotechnology innovations. Her work has been instrumental in advancing the capabilities of these organizations in the field.
Collaborations
Feigl has collaborated with esteemed colleagues, including Manfred Reiter and Wolfgang Mundt. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the biotechnology community.
Conclusion
Simone Feigl's contributions to the field of biotechnology, particularly in the production of continuous cell lines, highlight her role as an influential inventor. Her patents and collaborations reflect her commitment to advancing scientific research and innovation.